ZVRA · Zevra Therapeutics, Inc. · Documents
$10.33
-0.03 (-0.29%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$614.03M
Shares
59.38M
Volume · Oct 22
537.3K
Avg daily vol (3M)
1.05M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-05-08 | — | |
| DEFA14A | — | 2024-04-29 | — | |
| 8-K | — | 2024-04-10 | 2024-04-04 | |
| S-3/A | — | 2024-04-08 | — | |
| DEFA14A | — | 2024-04-03 | — | |
| DEF 14A | — | 2024-04-03 | 2024-05-13 | |
| 10-K | — | 2024-04-01 | 2023-12-31 | |
| 8-K | — | 2024-03-28 | — | |
| 8-K | — | 2024-03-27 | 2024-03-26 | |
| 8-K | — | 2024-03-05 | — | |
| 8-K | — | 2024-03-04 | — | |
| 8-K | — | 2024-02-28 | 2024-02-22 | |
| S-3 | — | 2024-02-05 | — | |
| 8-K/A | — | 2024-02-05 | 2023-11-20 | |
| 8-K | — | 2024-01-23 | — | |
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-27 | 2023-12-22 | |
| 8-K | — | 2023-11-20 | — | |
| 8-K | — | 2023-11-07 | — | |
| 10-Q | — | 2023-11-07 | 2023-09-30 | |
| 8-K | — | 2023-10-30 | — | |
| 8-K | — | 2023-10-10 | 2023-10-07 | |
| S-4/A | — | 2023-10-06 | — | |
| S-4 | — | 2023-09-29 | — | |
| 8-K | — | 2023-08-31 | — | |
| 8-K | — | 2023-08-31 | 2023-08-30 | |
| DEFA14A | — | 2023-08-31 | — | |
| 8-K | — | 2023-08-14 | — | |
| 10-Q | — | 2023-08-14 | 2023-06-30 | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-05-15 | 2023-05-13 | |
| 10-Q | — | 2023-05-15 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | 2023-05-03 | |
| 8-K | — | 2023-04-26 | 2023-04-25 | |
| DEFA14A | — | 2023-04-17 | — | |
| DEFA14A | — | 2023-04-05 | — | |
| DEFA14A | — | 2023-04-03 | — | |
| 8-K | — | 2023-03-30 | 2023-03-27 | |
| DEFA14A | — | 2023-03-30 | — | |
| DEFA14A | — | 2023-03-29 | — | |
| DEFA14A | — | 2023-03-29 | — | |
| DEFA14A | — | 2023-03-29 | — | |
| DEFA14A | — | 2023-03-17 | — | |
| DEFA14A | — | 2023-03-16 | — | |
| DEFA14A | — | 2023-03-15 | — | |
| 8-K | — | 2023-03-13 | — | |
| 10-K | — | 2023-03-07 | 2022-12-31 | |
| 8-K | — | 2023-03-07 | — | |
| DEFA14A | — | 2023-03-07 | — | |
| 8-K | — | 2023-02-27 | — |
Showing 51–100 of 202 filings
Key facts
CIK
1434647
CUSIP
488445206
13F (30d)
22 filings
22 filers
Visit website
Investor relations